The Hong Kong-68 influenza A2 variant.

PubWeight™: 5.25‹?› | Rank: Top 1%

🔗 View Article (PMID 4177941)

Published in Lancet on December 28, 1968

Authors

M T Coleman, W R Dowdle, H G Pereira, G C Schild, W K Chang

Articles citing this

Evolution and ecology of influenza A viruses. Microbiol Rev (1992) 39.99

Independent variation in nature of hemagglutinin and neuraminidase antigens of influenza virus: distinctiveness of hemagglutinin antigen of Hong Kong-68 virus. Proc Natl Acad Sci U S A (1969) 4.84

Influenza hemagglutinin and neuraminidase membrane glycoproteins. J Biol Chem (2010) 2.65

Response of ferrets and monkeys to intranasal infection with human, equine and avian influenza viruses. Can J Comp Med (1971) 2.01

An antigenic variant of the Hong Kong-68 influenza A 2 virus. J Hyg (Lond) (1971) 1.95

Relationship of envelope antigens of animal influenza viruses to human A2 influenza strains isolated in the years 1957-68. Bull World Health Organ (1969) 1.85

Antigenic variation in current influenza A viruses: evidence for a high frequency of antigenic 'drift' for the Hong Kong virus. Bull World Health Organ (1974) 1.68

Antigenic variation in current human type A influenza viruses: antigenic characteristics of the variants and their geographic distribution. Bull World Health Organ (1973) 1.60

Hong Kong influenza in the Royal Air Force 1968-70. J Hyg (Lond) (1973) 1.41

Studies on relationships between human and porcine influenza. 1. Serological evidence of infection in swine in Great Britain with an influenza A virus antigenically like human Hong Kong-68 virus. Bull World Health Organ (1972) 1.40

First outbreak of Hong Kong influenza in a general practice population in Great Britain. A field and laboratory study. Br Med J (1970) 1.40

Changes in the antibody status of a population following epidemic infection by influenza virus A2-Hong Kong-1-68. J Hyg (Lond) (1970) 1.37

Disruption of myxoviruses with Tween 20 and isolation of biologically active hemagglutinin and neuraminidase subunits. J Virol (1969) 1.37

Experimental infection in man and horses with influenza A viruses. Bull World Health Organ (1969) 1.35

Influenza pandemic periodicity, virus recycling, and the art of risk assessment. Emerg Infect Dis (2006) 1.34

Influenza A neuraminidase antibody assay with sensitized erythrocytes. Appl Microbiol (1973) 1.26

Properties of the Hong Kong influenza virus. I. General characteristics of the Hong Kong virus. Bull World Health Organ (1969) 1.19

Biophysical and immunological studies on the differential effect of guanidine hydrochloride on type A and type B influenza viruses. J Hyg (Lond) (1974) 1.18

Antibodies to influenza viruses (including the human A2-Asian-57 strain) in sera from Australian shearwaters (Puffinus pacificus). Bull World Health Organ (1970) 1.11

Interpretations of influenza antibody patterns of man. Bull World Health Organ (1969) 1.08

Serological diagnosis of human influenza infections by immunoprecipitin techniques. Bull World Health Organ (1971) 1.08

Immunological interrelationships of Hong Kong, Asian and equi-2 influenza viruses in man. Bull World Health Organ (1969) 1.07

A comparison of monovalent Hong Kong influenza virus vaccine with vaccines containing only pre-1968 Asian strains in adult volunteers. A report to the Medical Research Council Committee on Influenza and other Respiratory Virus Vaccines. J Hyg (Lond) (1970) 1.02

The role of antineuraminidase antibody in immunity to influenza virus infection. Bull World Health Organ (1969) 1.00

The Protein Maker: an automated system for high-throughput parallel purification. Acta Crystallogr Sect F Struct Biol Cryst Commun (2011) 0.99

Studies on relationships between human and porcine influenza. 2. Immunological comparisons of human A-Hong Kong-68 virus with influenza A viruses of porcine origin. Bull World Health Organ (1972) 0.96

Purified viral neuraminidase vaccine to control influenza. Can Med Assoc J (1979) 0.87

The epidemiological and public health research response to 2009 pandemic influenza A(H1N1): experiences from Hong Kong. Influenza Other Respir Viruses (2012) 0.86

Antibodies to human influenzavirus neuraminidase (the A-Asian-57 H2N2 strain) in sera from Australian pelagic birds. Bull World Health Organ (1972) 0.85

Some observations on the circulation of influenzaviruses in domestic and wild birds. Bull World Health Organ (1972) 0.81

Hong Kong influenza in the Sudan. Bull World Health Organ (1971) 0.81

Epidemic disease in Hong Kong, 1968, associated with an antigenic variant of Asian influenza virus. Am J Public Health Nations Health (1970) 0.77

Selecting vaccine strains for H3N2 human influenza A virus. Meta Gene (2015) 0.77

Inactivation of the hemagglutinins of type A influenza viruses by physical and chemical means: an aid to classification. Infect Immun (1972) 0.75

The influenza virus: Antigenic composition and immune response. Postgrad Med J (1979) 0.75

Preventing flu. Br Med J (1969) 0.75

New influenza. Br Med J (1972) 0.75

Articles by these authors

Legionnaires' disease: isolation of a bacterium and demonstration of its role in other respiratory disease. N Engl J Med (1977) 25.00

Influenzavirus neuraminidase and neuraminidase-inhibition test procedures. Bull World Health Organ (1973) 10.70

The epidemiology of AIDS: current status and future prospects. Science (1985) 8.73

Increased neurovirulence associated with a single nucleotide change in a noncoding region of the Sabin type 3 poliovaccine genome. Nature (1985) 6.01

Molecular mechanisms of variation in influenza viruses. Nature (1982) 5.54

Association of antigenic type of Herpesvirus hominis with site of viral recovery. J Immunol (1967) 5.07

A serologic study of herpesvirus hominis strains by microneutralization tests. J Immunol (1967) 4.39

Evidence for host-cell selection of influenza virus antigenic variants. Nature (1983) 4.24

The nucleotide sequence of poliovirus type 3 leon 12 a1b: comparison with poliovirus type 1. Nucleic Acids Res (1983) 4.06

Comparison of the complete nucleotide sequences of the genomes of the neurovirulent poliovirus P3/Leon/37 and its attenuated Sabin vaccine derivative P3/Leon 12a1b. Proc Natl Acad Sci U S A (1984) 3.98

Single-radial-hemolysis: a new method for the assay of antibody to influenza haemagglutinin. Applications for diagnosis and seroepidemiologic surveillance of influenza. Bull World Health Organ (1975) 3.88

The polypeptide composition of influenza A viruses. Virology (1971) 3.79

A quantitative, single-radial-diffusion test for immunological studies with influenza virus. J Gen Virol (1972) 3.69

Location and primary structure of a major antigenic site for poliovirus neutralization. Nature (1983) 3.64

Antigenic and biologic differences in herpesvirus hominis. Prog Med Virol (1968) 3.31

A common surface antigen in influenza viruses from human and avian sources. J Gen Virol (1968) 3.20

Characterization of the ribonucleoprotein and neuraminidase of influenza A viruses by immunodiffusion. J Gen Virol (1969) 3.11

Prevalence of antibody to current influenza viruses and effect of vaccination on antibody response. Br Med J (1972) 3.10

The receptor-binding and membrane-fusion properties of influenza virus variants selected using anti-haemagglutinin monoclonal antibodies. EMBO J (1987) 3.03

Avian influenza A viruses. Bull World Health Organ (1965) 3.02

The epidemiology of AIDS. Public Health Rep (1983) 3.00

Swine influenza viruses isolated in 1976 from man and pig contain two coexisting subpopulations with antigenically distinguishable hemagglutinins. Virology (1977) 2.90

Genetic basis of attenuation of the Sabin type 3 oral poliovirus vaccine. J Virol (1989) 2.89

Alterations in the hemagglutinin associated with adaptation of influenza B virus to growth in eggs. Virology (1985) 2.71

Neuraminidase and resistance to vaccination with live influenza A2 Hong Kong vaccines. J Hyg (Lond) (1971) 2.70

Antigens and structure of the adenovirus. J Mol Biol (1965) 2.69

Protective effect of 1-adamantanamine hydrochloride on influenza A2 infections in the family environment: a controlled double-blind study. Lancet (1969) 2.66

Antigenic similarity of influenza A (H1N1) viruses from epidemics in 1977--1978 to "Scandinavian" strains isolated in epidemics of 1950--1951. Virology (1978) 2.61

Structural changes in the haemagglutinin which accompany egg adaptation of an influenza A(H1N1) virus. Virology (1987) 2.58

Antibody responses to antigenic determinants of influenza virus hemagglutinin. I. Thymus dependence of antibody formation and thymus independence of immunological memory. J Exp Med (1974) 2.54

Antigenic relationship between influenza A viruses of human and avian origins. Nature (1967) 2.48

An improved single-radial-immunodiffusion technique for the assay of influenza haemagglutinin antigen: application for potency determinations of inactivated whole virus and subunit vaccines. J Biol Stand (1977) 2.46

Genital infection with type 2 Herpes virus hominis. A commonly occurring venereal disease. Br J Vener Dis (1969) 2.40

Antibody responses and resistance to challenge in volunteers vaccinated with live attenuated, detergent split and oil adjuvant A2-Hong Kong-68 (H 3 N 2 ) influenza vaccines. A report to the Medical Research Council Committee on Influenza and other Respiratory Virus Vaccines. J Hyg (Lond) (1972) 2.40

Monoclonal antibodies which block cellular receptors of poliovirus. Virus Res (1984) 2.40

Relation of pock size on chorioallantoic membrane to antigenic type of herpesvirus hominis. Proc Soc Exp Biol Med (1968) 2.34

Effect of rubella vaccination programme on serological status of young adults in United Kingdom. Lancet (1979) 2.31

Studies with inactivated influenza vaccines purified by zonal centrifugation. 1. Adverse reactions and serological responses. Bull World Health Organ (1969) 2.28

New antigenic variants of avian influenza A viruses. Bull World Health Organ (1966) 2.25

Antibody responses to antigenic determinants of influenza virus hemagglutinin. II. Original antigenic sin: a bone marrow-derived lymphocyte memory phenomenon modulated by thymus-derived lymphocytes. J Exp Med (1974) 2.25

Adult pneumonia in a general hospital. Etiology and host risk factors. Arch Intern Med (1972) 2.24

Segregation of antigenic and biological characteristics during influenza virus recombination. J Gen Virol (1972) 2.18

Evidence for a new type-specific structural antigen of the influenza virus particle. J Gen Virol (1972) 2.17

Antibody against influenza A2 virus neuraminidase in human sera. J Hyg (Lond) (1969) 2.12

Isolation of swine influenza virus from autopsy lung tissue of man. N Engl J Med (1976) 2.09

Antigenic composition of recombinant virus strains produced from human and avian influenza A viruses. J Gen Virol (1969) 2.01

Stopping poliovirus vaccination after eradication: issues and challenges. Bull World Health Organ (2000) 2.00

An antigenic variant of the Hong Kong-68 influenza A 2 virus. J Hyg (Lond) (1971) 1.95

The effect of heat on the anatomy of the adenovirus. J Gen Virol (1967) 1.92

Related studies of a recombinant influenza-virus vaccine. I. Derivation and characterization of virus and vaccine. J Infect Dis (1971) 1.90

Identification and preliminary antigenic analysis of swine influenza-like viruses isolated during an influenza outbreak at Fort Dix, New Jersey. J Infect Dis (1977) 1.88

Serological epidemiological studies with influenza A viruses. J Hyg (Lond) (1965) 1.86

Genetic interaction between influenza A viruses of human and animal origin. Virology (1965) 1.83

Immunological relationships between the neuraminidases of human and animal influenza viruses. Bull World Health Organ (1969) 1.82

Monoplegia caused by Enterovirus 71: an outbreak in Hong Kong. Pediatr Infect Dis J (1987) 1.81

Natural history of influenza type A in the United States, 1957-1972. Prog Med Virol (1974) 1.79

Monoclonal antibodies specific for the Sabin vaccine strain of poliovirus 3. Lancet (1982) 1.76

Trials in man with live recombinants made from A/PR/8/34 (H0 N1) and wild H3 N2 influenza viruses. Lancet (1975) 1.74

Inhibition of influenza viruses in vitro and in vivo by 1-adamantanamine hydrochloride. Br J Exp Pathol (1965) 1.73

Airways function during mild viral respiratory illnesses. The effect of rhinovirus infection in cigarette smokers. Ann Intern Med (1974) 1.72

Principal and subsidiary antigenic sites of VP1 involved in the neutralization of poliovirus type 3. J Gen Virol (1985) 1.72

Reversion to neurovirulence of the live-attenuated Sabin type 3 oral poliovirus vaccine. Nucleic Acids Res (1984) 1.71

Antigenic variation in current influenza A viruses: evidence for a high frequency of antigenic 'drift' for the Hong Kong virus. Bull World Health Organ (1974) 1.68

Immunological and physicochemical studies of influenza matrix (M) polypeptides. Virology (1976) 1.66

A proposed terminology for the adenovirus antigens and virion morphological subunits. Virology (1966) 1.66

Protein composition of coronavirus OC 43. Virology (1972) 1.66

The specificity of the anti-haemagglutinin antibody response induced in man by inactivated influenza vaccines and by natural infection. J Hyg (Lond) (1979) 1.65

Influenza: antigenic spectrum. Prog Med Virol (1969) 1.63

Enteric viruses and diarrhea in HIV-infected patients. Enteric Opportunistic Infections Working Group. N Engl J Med (1993) 1.60

Antigenic variation in current human type A influenza viruses: antigenic characteristics of the variants and their geographic distribution. Bull World Health Organ (1973) 1.60

Studies on inactivated influenza vaccines. II. Effect of increasing dosage on antibody response and adverse reactions in man. Am J Epidemiol (1970) 1.60

An investigation of some factors affecting cross-reactivation between influenza A viruses. J Gen Virol (1971) 1.59

WHO collaborative study on the sero-epidemiology of rubella in Caribbean and Middle and South American populations in 1968. Bull World Health Organ (1970) 1.58

Phosphorylated polypeptides in adenovirus-infected cells. Virology (1972) 1.58

Age-related heterologous antibody responses to influenza virus vaccination. J Infect Dis (1977) 1.57

Neuraminidase in avin influenza A virus antigenically related to that of human A0 and A1 subtypes. Nature (1969) 1.56

Inactivated influenza vaccines. 2. Laboratory indices of protection. Postgrad Med J (1973) 1.56

Studies with antibody to the purified haemagglutinin of an influenza Ao virus. J Gen Virol (1970) 1.56

Coronaviridae. Intervirology (1975) 1.55

Studies with inactivated influenza vaccines purified by zonal centrifugation. 2. Efficacy. Bull World Health Organ (1969) 1.55

Swine influenza virus infections in humans. J Infect Dis (1977) 1.50

Antigenic variation among avian influenza A viruses. Bull World Health Organ (1967) 1.49

Therapeutic effect of 1-adamantanamine hydrochloride in naturally occurring influenza A 2 -Hong Kong infection. A controlled double-blind study. Lancet (1971) 1.49

Reactogenicity and immunogenicity of inactivated influenza A (H1N1) virus vaccine in unprimed children. Report to the Medical Research Council Committee on influenza and other respiratory virus vaccines. J Biol Stand (1980) 1.48

Antigenic analysis of influenza A virus surface antigens: considerations for the nomenclature of influenza virus. Brief review. Arch Virol (1980) 1.46